Jubilant Ingrevia augments CDMO presence with Rs 270 crore contract

18 Apr 2022 Evaluate

Jubilant Ingrevia has bagged a CDMO contract for estimated value of Rs 270 Crore in Specialty Chemicals business, spanning over a period of three years with one of its international customers, who is among the top 10 leading innovator pharmaceutical companies globally.

Through the contract the Company will supply Two key GMP intermediates for one of the ‘patented drugs’ of the Innovator Pharmaceutical customer. Both these products involve 7 steps specialised chemistry. The Company was awarded these CDMO projects few years back and with extensive work in R&D and Scale-up, it has successfully demonstrated its capability in Process development, optimisation and scaling-up of complex chemistries. Commercial supplies of both these products will start from FY’23 onwards. The Company will use GMP facility to service this contract.

Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers.

Jubilant Ingrevia Share Price

700.80 14.25 (2.08%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3635.80
Tata Chemicals 755.60
SRF 3025.85
Pidilite Inds. 1476.20
Deepak Nitrite 1547.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×